Webinar: Redefining Genome Editing for Therapeutic Manufacturing with STAR-CRISPR™

Published on October 21, 2025
Webinar: Redefining Genome Editing for Therapeutic Manufacturing with STAR-CRISPR™

Join the webinar: Redefining Genome Editing for Therapeutic Manufacturing with STAR-CRISPR™

Wednesday, November 19 | 5 PM CET | 11 AM EST | 8 AM PST

As the cell therapy field advances, developers face an ongoing challenge: achieving precise, efficient, and safe genome edits at manufacturing scale.

Join Dr. Stefan Braam and Dr. Suzanne Snellenberg from Cellistic for an in-depth look at STAR-CRISPR™, a next-generation genome editing technology that combines high on-target precision, multiplex capability, and unmatched genomic stability.

Continue reading on website
Other news

Pharma’s real-world data dilemma: Strategic asset or wasted resource?

October 17, 2025
Every day, patients are experiencing the life-changing impact of real-world data (RWD), and life sciences companies are feeling the business impact, too. RWD is no doubt helping pharma companies better understand the patient journey and get life-saving therapies to market faster, according to Norstella’s recent survey of 200 life science executives. Over the next one […]

InnovAge to Announce Fiscal First Quarter 2026 Financial Results and Host Conference Call Tuesday, November 4, 2025

October 21, 2025
DENVER, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today